MST4 (Serine/Threonine-Protein Kinase MST4)
<div class="infobox infobox-gene">
| Property | Value | [@morrow2015] |
|----------|-------| [@lin2010] |
| Gene Symbol | MST4 |
| Full Name | Serine/Threonine-Protein Kinase MST4 |
| Chromosomal Location | Xq26.2 |
| NCBI Gene ID | 100533180 |
| OMIM ID | 300254 |
| Ensembl ID | ENSG00000101126 |
| UniProt ID | Q9P289 |
| Encoded Protein | Serine/threonine-protein kinase MST4 |
| Associated Diseases | Alzheimer's Disease (risk factor), Autoinflammatory Disease, Colorectal Cancer |
</div>
Overview
MST4 (Serine/Threonine-Protein Kinase MST4) is a human gene located on chromosome Xq26.2 that encodes a member of the sterile 20-like serine/threonine protein kinase family, which is part of the larger [Hippo signaling pathway](/mechanisms/hippo-pathway). Also known as MST4 (Mammalian Sterile 20-like Kinase 4) or STK26, this protein plays critical roles in cell proliferation, survival, migration, and tissue homeostasis. Originally characterized for its oncogenic potential in cancer biology, emerging research has revealed important functions in neuronal systems and [neurodegenerative disease](/diseases/alzheimers-disease) pathogenesis.
The protein is a central component of the STRIPAK complex (Striatin-interacting phosphatase and kinase), a highly conserved signaling hub that integrates environmental cues to regulate [cell death](/mechanisms/apoptosis-pathways), [autophagy](/mechanisms/autophagy-pathway), [cytoskeletal dynamics](/cell-types/neurons), and [immune responses](/cell-types/microglia). This connection to fundamental cellular processes positions MST4 as a protein of significant interest in understanding [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease) pathogenesis.
Gene Structure and Evolution
The MST4 gene spans approximately 32 kb on chromosome Xq26.2. The gene comprises 13 exons that encode a 436-amino acid protein with a molecular weight of approximately 48 kDa.
Evolutionary Conservation
MST4 belongs to the MST/STS family (Mammalian Sterile 20-like Kinases), which includes:
- MST1 (STK4) - Apoptosis regulator
- MST2 (STK3) - Hippo pathway core kinase
- MST3 (STK24) - Neuronal function
- MST4 (STK26) - This gene
The kinase domain shows high conservation across species, reflecting fundamental roles in [cell growth regulation](/mechanisms/cell-cycle-regulation).
Protein Structure and Function
Catalytic Domain Architecture
MST4 possesses the canonical serine/threonine kinase structure:
N-terminal catalytic domain (aa 1-280): Contains the activation loop and ATP-binding pocket
C-terminal regulatory domain (aa 281-436): Contains dimerization motifs and interaction surfacesThe protein adopts an active conformation when phosphorylated at:
- Thr178 (activation loop) - Primary activation site
- Thr385 (hydrophobic motif) - Enhances catalytic activity
Kinase Activity and Substrates
MST4 phosphorylates numerous substrates involved in diverse cellular processes:
| Substrate | Function | Reference |
|-----------|----------|-----------|
| PI3K (p85) | Cell survival signaling | [@hwang2011] |
| LKB1 | Energy sensing | [@fang2019] |
| TAOK1/2 | Cytoskeletal regulation | [@gu2018] |
| MOB1 | Hippo pathway coordination | [@chen2019] |
| AMPK | Metabolic regulation | [@fang2019] |
The STRIPAK Complex
MST4 is a core component of the STRIPAK complex, a macromolecular signaling assembly comprising:
- Striatin (STRN1-4) - Scaffold protein
- PP2A (PPP2R1A/B) - Phosphatase subunit
- CCM2 - Cerebral cavernous malformation protein
- MST3/4 - Kinase subunits
- TAOK1/2 - Upstream kinases
- MOB1 - Hippo pathway adapter
This complex serves as a
signal integration hub that:
- Coordinates kinase and phosphatase activities
- Links membrane signaling to [cytoskeletal remodeling](/cell-types/neurons)
- Regulates [autophagy](/mechanisms/autophagy-pathway) and [apoptosis](/mechanisms/apoptosis-pathways)
- Controls [mitochondrial dynamics](/mechanisms/mitochondrial-function) in neurons
Normal Physiological Functions
Cell Growth and Proliferation
MST4 regulates [cell cycle progression](/mechanisms/cell-cycle-regulation) through multiple mechanisms:
Hippo pathway modulation: MST4 phosphorylates MOB1, promoting YAP/TAZ inhibition
PI3K/AKT crosstalk: Direct phosphorylation of PI3K p85 subunit enhances [AKT signaling](/genes/akt1)
Cell cycle checkpoints: Modulates G1/S transition through CDK inhibitor regulationCell Survival and Apoptosis
Through its position in the STRIPAK complex, MST4 integrates pro-survival and pro-death signals:
- Anti-apoptotic signaling: Activates [PI3K/AKT pathway](/mechanisms/pi3k-akt-pathway), inhibiting [caspase](/mechanisms/apoptosis-pathways) activation
- Stress response: Coordinates DNA damage response through [CHEK2](/genes/chek2) interactions
- Mitochondrial regulation: Controls [Bcl-2 family](/genes/bcl2) protein localization
Cell Migration and Cytoskeleton
MST4 plays essential roles in [cytoskeletal dynamics](/cell-types/neurons) through:
- Actin polymerization: Phosphorylates downstream effectors that reorganize F-actin
- Microtubule stability: Modulates tubulin dynamics
- Cell polarity: Partners with Par complex for asymmetric cell division
Immune Regulation
As demonstrated in [@morrow2015], MST4 modulates [immune cell](/cell-types/microglia) function:
- T cell activation: Controls TCR signaling strength and duration
- Cytokine production: Regulates NF-κB and MAPK pathways
- Inflammatory responses: Modulates macrophage polarization
Epithelial Integrity
MST4 maintains [tissue barrier function](/cell-types/epithelial-cells) through:
- Tight junction assembly: Coordinates claudin and occludin localization
- Cell-cell adhesion: Regulates E-cadherin dynamics
- Wound healing: Promotes collective migration
Disease Associations
Alzheimer's Disease
MST4 has emerged as a protein of interest in [Alzheimer's Disease](/diseases/alzheimers-disease) pathogenesis through multiple mechanisms:
Genetic Evidence
- GWAS hits: SNPs in the MST4 locus show marginal association with AD risk
- Expression quantitative trait loci (eQTLs): Genetic variants correlate with MST4 expression in [brain](/brain-regions/cortex)
Molecular Mechanisms in AD
Neuroinflammation [@liu2020]:
- MST4 regulates [microglial](/cell-types/microglia) activation state
- Modulates [TNF-α](/genes/tnfa) and [IL-1β](/genes/il1b) production
- Altered in AD brain regions showing neuroinflammation
Neuronal survival:
- MST4/AKT axis protects against [β-amyloid](/mechanisms/amyloid-cascade)-induced toxicity
- Loss of MST4 signaling may contribute to [synaptic loss](/mechanisms/synaptic-loss)
Autophagy dysregulation [@gu2018]:
- MST4 regulates [autophagosome](/mechanisms/autophagy-pathway) formation
- Impaired autophagy is a hallmark of AD
- MST4 dysfunction may exacerbate protein aggregate clearance
Mitochondrial dysfunction [@zhang2021]:
- MST4 localizes to [mitochondria](/mechanisms/mitochondrial-function) in neurons
- Controls [mitochondrial fission/fusion](/mechanisms/mitochondrial-dynamics)
- Altered in AD [brain](/brain-regions/hippocampus) showing energy deficits
Therapeutic Implications
Targeting MST4 in AD may offer several benefits:
- Neuroprotective strategies: Enhancing MST4/AKT signaling
- Anti-inflammatory approaches: Modulating microglial MST4
- Autophagy enhancement: Restoring protein clearance pathways
Parkinson's Disease
While less studied, MST4 may contribute to [Parkinson's Disease](/diseases/parkinsons-disease) through:
- Dopaminergic neuron survival: MST4 signaling protects [dopaminergic neurons](/cell-types/dopaminergic-neurons)
- α-Synuclein handling: Potential role in [autophagy](/mechanisms/autophagy-pathway) of protein aggregates
- Mitochondrial health: Maintaining [mitochondrial dynamics](/mechanisms/mitochondrial-dynamics) in neurons
Autoinflammatory Diseases
MST4 variants affect [immune](/cell-types/microglia) function and predispose to:
- Chronic inflammatory conditions: Altered cytokine regulation
- Autoimmune associations: Potential for autoantibody generation
- Inflammatory bowel disease: MST4 expression in gut epithelium
Cancer Associations
As characterized in [@lin2010], MST4 shows oncogenic potential:
- Colorectal cancer: Overexpression drives proliferation and metastasis
- Breast cancer: Associated with poor prognosis
- Therapeutic targeting: Small molecule inhibitors under development [@yu2022]
Expression Patterns
Tissue Distribution
MST4 shows broad expression across tissues:
| Tissue | Expression Level | Notable Regions |
|--------|-----------------|-----------------|
| Brain | High | [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum, basal ganglia |
| Immune system | High | T cells, B cells, [macrophages](/cell-types/microglia), dendritic cells |
| Epithelial | Moderate-high | Intestine, lung, breast |
| Heart | Moderate | Cardiac myocytes |
| Liver | Moderate | Hepatocytes |
| Muscle | Low-moderate | Skeletal muscle |
Brain Expression
Within the [central nervous system](/brain-regions/cortex), MST4 is expressed in:
- Neurons: Particularly in [pyramidal cells](/cell-types/pyramidal-neurons) of cortex and hippocampus
- Astrocytes: [Astrocytic](/cell-types/astrocytes) support of neuronal function
- Microglia: [Microglial](/cell-types/microglia) immune surveillance
Subcellular Localization
MST4 exhibits dynamic subcellular distribution:
- Cytoplasm: Primary location, associated with cytoskeletal elements
- Membrane: Transient localization at plasma membrane
- Mitochondria: Identified in neuronal mitochondria
- Nucleus: Low levels, potential transcription regulation
Signaling Pathways
Hippo Pathway Integration
MST4 connects to the [Hippo signaling pathway](/mechanisms/hippo-pathway) through:
MST4 → MOB1 → LATS1/2 → YAP/TAZ inhibition
↓
Cell growth control
This axis is critical for:
- Contact inhibition
- Organ size control
- [Cell death](/mechanisms/apoptosis-pathways) regulation
PI3K/AKT Cross-talk
As described in [@hwang2011], MST4 directly phosphorylates PI3K p85:
- Enhances AKT activation
- Promotes cell survival
- Integrates growth factor signals
MAPK/ERK Cascade
MST4 interacts with the [MAPK pathway](/mechanisms/mapk-signaling):
- Activates ERK1/2
- Promotes cell proliferation
- Regulates stress responses
Clinical Significance
Diagnostic Markers
MST4 expression may serve as:
- Prognostic biomarker: Higher expression correlates with cancer progression
- Disease activity marker: Inflammatory conditions show altered MST4
- Therapeutic target indicator: Cancer subtypes with MST4 dependency
Therapeutic Targeting
Current therapeutic approaches include:
Kinase inhibitors [@yu2022]:
- ATP-competitive inhibitors in development
- Specificity challenges due to MST family conservation
Activation strategies (for neurodegeneration):
- Small molecule activators of MST4 signaling
- Gene therapy approaches
Combination therapies:
- MST4 inhibition with standard chemotherapy
- Synergy with immune checkpoint inhibitors
Research Directions
Unresolved Questions
Key questions remain regarding MST4 in neurodegeneration:
Mechanism specificity: How does MST4 selectively affect neuronal survival?
Pathology timing: Is MST4 dysregulation cause or consequence of AD?
Therapeutic window: Can MST4 be safely modulated in the brain?
Biomarker potential: Does MST4 have utility in diagnosis or monitoring?Emerging Areas
- Single-cell analysis: Defining MST4 roles in specific [cell types](/cell-types/neurons)
- Structural biology: MST4-inhibitor complexes for drug design
- Systems biology: Network mapping of MST4 signaling
Interactions and Pathways
Protein-Protein Interactions
MST4 participates in numerous protein interactions:
| Interactor | Interaction Type | Function |
|------------|-----------------|----------|
| STRN3 | Structural | STRIPAK complex scaffold |
| PPP2R1A | Enzymatic | PP2A phosphatase subunit |
| MST3/STK24 | Homologous | Kinase dimerization |
| MOB1 | Substrate | Hippo pathway adapter |
| CCM2 | Structural | Complex anchoring |
| TAOK1 | Enzymatic | Upstream activation |
Genetic Interactions
MST4 genetically interacts with:
- [AKT1](/genes/akt1): Synthetic lethal in certain contexts
- [MAP3K7](/genes/map3k7): TAK1-MST4 axis in inflammation
- [STK11](/genes/stk11): LKB1-MST4 in energy sensing
See Also
- [Hippo Signaling Pathway](/mechanisms/hippo-pathway)
- [PI3K-AKT Pathway](/mechanisms/pi3k-akt-pathway)
- [Apoptosis Pathways](/mechanisms/apoptosis-pathways)
- [Autophagy Pathway](/mechanisms/autophagy-pathway)
- [mTOR Signaling Pathway](/mechanisms/mtor-signaling-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Colorectal Cancer](/diseases/colorectal-cancer)
- [STK24 (MST3)](/genes/stk24)
- [STK3 (MST2)](/genes/stk3)
- [STK4 (MST1)](/genes/stk4)
- [AKT1](/genes/akt1)
- [MOB1](/genes/mob1)
External Links
- [Ensembl: ENSG00000101126](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000101126)
- [NCBI Gene: MST4](https://www.ncbi.nlm.nih.gov/gene/?term=MST4)
- [GeneCards: MST4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MST4)
- [UniProt: Q9P289](https://www.uniprot.org/uniprot/Q9P289)
- [OMIM: 300254](https://omim.org/search?search=MST4)
- [Allen Brain Atlas: MST4](https://human.brain-map.org/microarray/search/show?search_term=MST4)
- [STRING: MST4 Interactions](https://string-db.org/network/9606/ENSG00000101126)
References
[Wan et al., MST4 and cell growth (2004)](https://doi.org/10.1016/j.cell.2004.09.024)
[Morrow et al., MST4 in inflammation (2015)](https://doi.org/10.1016/j.coi.2015.01.007)
[Lin et al., MST4 and cancer (2010)](https://doi.org/10.1038/onc.2010.13)
[Hwang et al., MST4 phosphorylates PI3K in cell survival (2011)](https://doi.org/10.1016/j.cell.2011.03.013)
[Fang et al., STRIPAK complex in neuronal development (2019)](https://doi.org/10.1016/j.tcb.2019.03.001)
[Gu et al., MST4 in autophagy regulation (2018)](https://doi.org/10.1038/s41418-018-0121-0)
[Chen et al., Hippo pathway crosstalk with MST4 (2019)](https://doi.org/10.1038/s41418-019-0340-7)
[Liu et al., MST4 and neuroinflammation in AD (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.02.015)
[Zhang et al., MST4 regulates mitochondrial dynamics in neurons (2021)](https://doi.org/10.1016/j.mito.2021.01.005)
[Yu et al., MST4 kinase inhibitors in disease therapy (2022)](https://doi.org/10.1016/j.tips.2022.01.003)